These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4029555)

  • 1. Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis.
    Sheen IS; Liaw YF; Tai DI; Chu CM
    Gastroenterology; 1985 Oct; 89(4):732-5. PubMed ID: 4029555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
    Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males.
    Fagan EA; Smith PM; Davison F; Williams R
    Lancet; 1986 Sep; 2(8506):538-40. PubMed ID: 2875281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease and the e antigen in HBsAg carriers with chronic renal failure.
    Coughlin GP; Van Deth AG; Disney AP; Hay J; Wangel AG
    Gut; 1980 Feb; 21(2):118-22. PubMed ID: 7380332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.
    Davis GL; Hoofnagle JH
    Ann Intern Med; 1985 Jun; 102(6):762-5. PubMed ID: 3994187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
    Hoofnagle JH; Dusheiko GM; Seeff LB; Jones EA; Waggoner JG; Bales ZB
    Ann Intern Med; 1981 Jun; 94(6):744-8. PubMed ID: 7235415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of HBV serological markers in patients with chronic hepatitis].
    Cichoz-Lach H; Słomka M; Daniluk J; Celiński K; Pokora J
    Pol Arch Med Wewn; 1992 Oct; 88(4):244-9. PubMed ID: 1488325
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopathogenesis of hepatitis B virus infection.
    Chang JJ; Lewin SR
    Immunol Cell Biol; 2007 Jan; 85(1):16-23. PubMed ID: 17130898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children.
    Chang MH; Sung JL; Lee CY; Chen CJ; Chen JS; Hsu HY; Lee PI; Chen DS
    J Pediatr; 1989 Sep; 115(3):385-90. PubMed ID: 2769497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the HBeAg/anti-HBe system in hepatitis B infection.
    Frösner GG
    Riv Emoter Immunoematol; 1980; 27(1-2):85-7. PubMed ID: 7466190
    [No Abstract]   [Full Text] [Related]  

  • 15. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
    Yoo SH; Jang JW; Kwon JH; Jung SM; Jang B; Choi JY
    Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulation of the hepatitis B virus in an institution for the severely handicapped. II. Employment of personnel having antibodies against the virus B surface antigen in the assistance to HBeAg-positive children].
    Biadaioli R; Losco D; De Martino M; Veneruso G; Vierucci A
    Ann Sclavo; 1983; 24(3):213-20. PubMed ID: 6615030
    [No Abstract]   [Full Text] [Related]  

  • 17. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute hepatic failure; is it a distinct entity?
    Tandon BN; Joshi YK; Krishnamurthy L; Tandon HD
    J Clin Gastroenterol; 1982 Aug; 4(4):343-6, 362-4. PubMed ID: 7119411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. e antigen in acute hepatitis B.
    Norkrans G; Magnius L; Iwarson S
    Br Med J; 1976 Mar; 1(6012):740-2. PubMed ID: 56971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
    Eleftheriou N; Thomas HC; Heathcote J; Sherlock S
    Lancet; 1975 Dec; 2(7946):1171-3. PubMed ID: 53657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.